NDC 69117-0046 Lamotrigine
View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Product Characteristics
GREEN (C48329)
ORANGE (C48331)
Y32
Y33
Code Structure Chart
Product Details
What is NDC 69117-0046?
What are the uses for Lamotrigine?
Which are Lamotrigine UNII Codes?
The UNII codes for the active ingredients in this product are:
- LAMOTRIGINE (UNII: U3H27498KS)
- LAMOTRIGINE (UNII: U3H27498KS) (Active Moiety)
Which are Lamotrigine Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- GLYCERYL MONO AND DIPALMITOSTEARATE (UNII: KC98RO82HJ)
- HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A (UNII: NX76LV5T8J)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- SHELLAC (UNII: 46N107B71O)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
What is the NDC to RxNorm Crosswalk for Lamotrigine?
- RxCUI: 1098608 - lamoTRIgine 300 MG 24HR Extended Release Oral Tablet
- RxCUI: 1098608 - 24 HR lamotrigine 300 MG Extended Release Oral Tablet
- RxCUI: 1098608 - lamotrigine 300 MG 24 HR Extended Release Oral Tablet
- RxCUI: 1146690 - lamoTRIgine 250 MG 24HR Extended Release Oral Tablet
- RxCUI: 1146690 - 24 HR lamotrigine 250 MG Extended Release Oral Tablet
* Please review the disclaimer below.
Patient Education
Lamotrigine
Lamotrigine extended-release (long-acting) tablets are used with other medications to treat certain types of seizures in patients who have epilepsy. All types of lamotrigine tablets (tablets, orally disintegrating tablets, and chewable tablets) other than the extended-release tablets are used alone or with other medications to treat seizures in people who have epilepsy or Lennox-Gastaut syndrome (a disorder that causes seizures and often causes developmental delays). All types of lamotrigine tablets other than the extended-release tablets are also used to increase the time between episodes of depression, mania (frenzied or abnormally excited mood), and other abnormal moods in patients with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lamotrigine has not been shown to be effective when people experience the actual episodes of depression or mania, so other medications must be used to help people recover from these episodes. Lamotrigine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".